Lupin Q2 net up 55% at Rs 630 cr

Lupin Q2 net up 55% at Rs 630 cr

FPJ BureauUpdated: Saturday, June 01, 2019, 07:14 AM IST
article-image

New Delhi : Drug major Lupin posted 55.11 % rise in its consolidated net profit at Rs 630.04 crore for the second quarter ended September, driven by robust sales in the US, Japan and domestic market.

Net sales rose to Rs 3,116.81 crore for the second quarter, as against Rs 2,631.46 crore during the same period last fiscal.  Lupin Ltd MD Nilesh Gupta said: “We have had a great first half driven by strong growth in US, India, Japan and our API business. Our research pipeline is evolving well and we expect significant developments in the dermatology and inhalation space in the quarters to come”.

US and Europe formulation sales grew by 23 per cent to Rs 1,359.2 crore.

RECENT STORIES

Rock Solid: Citroen Basalt Vision Revealed

Rock Solid: Citroen Basalt Vision Revealed

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Trade With Speed: India Launches World's Fastest T+0 Trade Settlement; Check Out The 25 Listed...

Century Textile Shares Rocket Bullishly; Surge Over 10%

Century Textile Shares Rocket Bullishly; Surge Over 10%

Adani's Copper Unit In Mundra Begins Operations

Adani's Copper Unit In Mundra Begins Operations

Renault Duster and Nissan SUV Teasers Released, Set To Debut In India In 2025

Renault Duster and Nissan SUV Teasers Released, Set To Debut In India In 2025